Literature DB >> 7049231

Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid.

C J Easton, J R Knowles.   

Abstract

From chemical and kinetic studies of the interaction of the RTEM beta-lactamase from Escherichia coli with three derivatives of olivanic acid, MM22382 (1), MM13902 (2), and MM4550 (3), a mechanism for the inhibition of the enzyme by these compounds is proposed: the interaction proceeds by formation of an acyl-enzyme, the delta 2-pyrroline, which may either deacylate or undergo tautomerization to the more tightly bound delta 1-pyrroline. The ability of olivanic acids to inhibit the enzyme thus depends on the partitioning of the acyl-enzyme to the delta 1-pyrroline ( a process that competes with the normal hydrolytic pathway) and on the rate of regeneration of free enzyme from this complex.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049231     DOI: 10.1021/bi00541a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants.

Authors:  Krisztina M Papp-Wallace; Magdalena A Taracila; Julian A Gatta; Nozomi Ohuchi; Robert A Bonomo; Michiyoshi Nukaga
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

Review 2.  Carbapenem-hydrolyzing beta-lactamases.

Authors:  B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

3.  Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.

Authors:  Lee W Tremblay; Fan Fan; John S Blanchard
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

4.  Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.

Authors:  C J Easton; J R Knowles
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 5.  Class D β-lactamases: a reappraisal after five decades.

Authors:  David A Leonard; Robert A Bonomo; Rachel A Powers
Journal:  Acc Chem Res       Date:  2013-07-31       Impact factor: 22.384

6.  Imipenem as substrate and inhibitor of beta-lactamases.

Authors:  J Monks; S G Waley
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

7.  Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

8.  Crystal structure of carbapenemase OXA-58 from Acinetobacter baumannii.

Authors:  Clyde A Smith; Nuno Tiago Antunes; Marta Toth; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

9.  Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.

Authors:  Sarah M Drawz; Maja Babic; Christopher R Bethel; Magda Taracila; Anne M Distler; Claudia Ori; Emilia Caselli; Fabio Prati; Robert A Bonomo
Journal:  Biochemistry       Date:  2010-01-19       Impact factor: 3.162

10.  Kinetic studies on the inhibition of Proteus vulgaris beta-lactamase by imipenem.

Authors:  T Hashizume; A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.